4556 Stock Overview
Engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
KAINOS Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,242.00 |
| 52 Week High | JP¥1,289.00 |
| 52 Week Low | JP¥1,055.00 |
| Beta | 0 |
| 1 Month Change | 3.24% |
| 3 Month Change | 7.44% |
| 1 Year Change | 13.42% |
| 3 Year Change | 14.36% |
| 5 Year Change | 34.71% |
| Change since IPO | 12.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4556 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 0.2% | -1.4% | -1.5% |
| 1Y | 13.4% | 14.7% | 13.7% |
Return vs Industry: 4556 underperformed the JP Medical Equipment industry which returned 14.7% over the past year.
Return vs Market: 4556 matched the JP Market which returned 13.7% over the past year.
Price Volatility
| 4556 volatility | |
|---|---|
| 4556 Average Weekly Movement | 2.5% |
| Medical Equipment Industry Average Movement | 3.6% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4556 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4556's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | n/a | Yukihiro Nagatsu | www.kainos.co.jp |
KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Test Kit, a liquid form creatinine measurement reagent kit for various makes of automatic analyzer systems; Aqua-auto Kainos ALB Test Kit, a liquid form reagent kit; and Aqua-auto Kainos UN-II Test Kit, a liquid urea nitrogen measurement reagent kit.
KAINOS Laboratories, Inc. Fundamentals Summary
| 4556 fundamental statistics | |
|---|---|
| Market cap | JP¥5.53b |
| Earnings (TTM) | JP¥82.76m |
| Revenue (TTM) | JP¥4.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs 4556 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4556 income statement (TTM) | |
|---|---|
| Revenue | JP¥4.44b |
| Cost of Revenue | JP¥2.89b |
| Gross Profit | JP¥1.55b |
| Other Expenses | JP¥1.47b |
| Earnings | JP¥82.76m |
Last Reported Earnings
Dec 31, 2010
Next Earnings Date
Jan 24, 2025
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 4556 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yieldn/a
Payout RatioDoes 4556 pay a reliable dividends?
See 4556 dividend history and benchmarks| KAINOS Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 23 2025 |
| Days until Ex dividend | 96 days |
| Days until Dividend pay date | 183 days |
Does 4556 pay a reliable dividends?
See 4556 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 09:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2010/12/31 |
| Annual Earnings | 2010/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
KAINOS Laboratories, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|